SCHEMBL13725426

SCHEMBL13725426

O=C(Oc1ccc(-c2ccccc2)cc1Cl)c1cccc2c1NC(C(=O)O)C1CC3OC3C21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN7 P35236 11/20 0.50
▸ POLB P06746 4/20 0.37
▸ TDP1 Q9NUW8 4/20 0.37
▸ L3MBTL1 Q9Y468 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ GAA P10253 4/20 0.37
▸ HPGD P15428 3/20 0.37
▸ THRB P10828 3/20 0.37
▸ BLM P54132 3/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ MCL1 Q07820 3/20 0.37
▸ USP2 O75604 2/20 0.37
▸ ALOX12 P18054 1/20 0.37
▸ GRK2 P25098 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ CDC25B P30305 1/20 0.37
▸ HSPA1A P0DMV8 5/20 0.36
▸ HSPA8 P11142 3/20 0.36
▸ CD44 P16070 1/20 0.36
▸ MSN P26038 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13725184 0.82 PTPN7 (0.75) PTPN7POLBTDP1L3MBTL1KMT2A
SCHEMBL13725206 0.65 PTPN7 (0.87) PTPN7POLBTDP1L3MBTL1KMT2A
SCHEMBL13725695 0.63 PTPN7 (0.74) PTPN7POLBTDP1L3MBTL1KMT2A
SCHEMBL13724862 0.63 PTPN7 (0.76) PTPN7POLBTDP1L3MBTL1KMT2A
SCHEMBL13725212 0.62 PTPN7 (0.88) PTPN7POLBTDP1L3MBTL1KMT2A
SCHEMBL13725616 0.62 PTPN7 (0.89) PTPN7POLBTDP1L3MBTL1KMT2A
SCHEMBL13724823 0.61 PTPN7 (0.85) PTPN7POLBTDP1L3MBTL1KMT2A
SCHEMBL13725254 0.60 PTPN7 (0.84) PTPN7POLBTDP1L3MBTL1KMT2A
SCHEMBL13725608 0.60 PTPN7 (0.82) PTPN7POLBTDP1L3MBTL1KMT2A
SCHEMBL13726135 0.59 PTPN7 (0.81) PTPN7POLBTDP1L3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203726-A1 SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS MAXTHERA INC. (US) 2009-08-13 — — US disclosed
US-20090203726-A1 SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS MAXTHERA INC. (US) 2009-08-13 — — US disclosed
WO-2009073550-A2 SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS MAXTHERA, INC. (US) 2009-06-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203726-A1 SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS NISCH, NDUFS3, SDHA PTPN7 3898/4885POLB 1343/4885TDP1 3729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback